Portfolio company
VIROBLOCK SA
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops antiviral technologies and air filtration products, such as face masks, to protect healthcare workers and the public from enveloped viruses.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Avidicare
This company manufactures air ventilation systems for hospitals and clinics to reduce airborne bacteria and prevent infections in operating rooms and sterile environments.
Avidicare AB
This company develops and sells specialised ventilation systems for hospital operating rooms to reduce surgical site infections by managing airborne bacteria and viruses.
Mask Logic
This company manufactures custom-fit respiratory face masks using 3D scanning technology for industrial and healthcare workers requiring personalised protective equipment.
Halo Therapeutics
This company develops small-molecule antiviral nasal sprays to treat respiratory viral infections for patients suffering from conditions like Covid-19.
99 Technologies
This company develops automated room and surface disinfection systems for healthcare providers to reduce infections in clinical and public settings.
Aerium Therapeutics
This biopharmaceutical company develops monoclonal antibodies and antiviral treatments to protect immunocompromised patients against COVID-19 and future epidemic threats.
LAM-X
This company develops light-activated antimicrobial nanofibre materials for wound care, medical device dressings and life science research applications for patients and healthcare providers.
SILVERbac
This company develops antimicrobial silver-infused polymers and fibres for manufacturers in the textile, healthcare and apparel industries.
